Compare Charles River Laboratories Intl. Inc (CRL) vs Domino's Pizza, Inc. (DPZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Domino's Pizza, Inc. — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Domino's Pizza, Inc. trades at $309.36 (market cap $10.21B). The key difference: Charles River Laboratories Intl. Inc is the larger of the two by market cap, and Domino's Pizza, Inc. pays a 2.58% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Domino's Pizza, Inc. for 106 Days on average.
| CRL | DPZ | |
|---|---|---|
Market Cap | $14.23B | $10.21B |
Volume | 1,176,885 | 916,737 |
Sector | Health | Consumer Cyclical |
52-Week High | $310.77 | $438.42 |
52-Week Low | $149.93 | $282.89 |
Typical Hold Time | 33 Days | 106 Days |
Enterprise Value | $17.06B | $15.17B |
Dividend Yield | — | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $301.79, up 0.5% with strong analyst support (73% buy ratings) and a $305.50 consensus target. The stock shows bullish technical momentum above key support levels, though fundamentals reveal challenges with negative net income margins (-5.96%) and elevated P/E ratio (684.85). Recent quarterly earnings beats and a new 2030 growth strategy provide optimism, but profitability concerns persist amid flat revenue trends.
The outlook balances near-term technical strength against fundamental headwinds. Investment opportunity lies in execution of the 5-7% growth target and $300M savings plan, while risks include sustained negative profitability, high debt levels ($2.24B), and margin pressure. Current price near resistance at $304 suggests limited upside without fundamental improvement.
DPZ trades at $309.36, up 2.07% today, amid a mixed technical and fundamental backdrop. The stock shows a bullish overall technical signal but has missed earnings estimates for three consecutive quarters. Revenue and net income have grown steadily, reaching $4.94 billion and $601.70 million in 2025, respectively, though profit margins are under slight pressure. Recent news highlights store closures and dividend stability concerns alongside promotional initiatives.
The outlook is cautiously optimistic, supported by analyst consensus but tempered by high debt and recent earnings misses. Investment opportunity lies in potential valuation expansion toward the $373 price target, while key risks include elevated leverage, competitive pressures, and execution challenges in maintaining growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Domino's Pizza, Inc.
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →
